hu.MAP 3.0: Complex View
Human Protein Complex Map
Search for a protein
Complex: huMAP3_10459.1
Complex Portal: CPX-24984
Confidence: Medium High  
ProteinsGenename | Protein Name | Uniprot Annotation Score | Links |
---|---|---|---|
IFNA1 | Interferon alpha-1/13 (IFN-alpha-1/13) (Interferon alpha-D) (LeIF D) | 5 | UniProt   NCBI |
IFNA17 | Interferon alpha-17 (IFN-alpha-17) (Interferon alpha-88) (Interferon alpha-I') (LeIF I) (Interferon alpha-T) | 5 | UniProt   NCBI |
IFNA7 | Interferon alpha-7 (IFN-alpha-7) (Interferon alpha-J) (LeIF J) (Interferon alpha-J1) (IFN-alpha-J1) | 5 | UniProt   NCBI |
IFI44L | Interferon-induced protein 44-like | 4 | UniProt   NCBI |
IFI44 | Interferon-induced protein 44 (p44) (Microtubule-associated protein 44) | 3 | UniProt   NCBI |
IFNA6 | Interferon alpha-6 (IFN-alpha-6) (Interferon alpha-54) (Interferon alpha-K) (LeIF K) | 5 | UniProt   NCBI |
IFNA5 | Interferon alpha-5 (IFN-alpha-5) (Interferon alpha-61) (Interferon alpha-G) (LeIF G) | 5 | UniProt   NCBI |
IFNA14 | Interferon alpha-14 (IFN-alpha-14) (Interferon alpha-H) (LeIF H) (Interferon lambda-2-H) | 5 | UniProt   NCBI |
TRIM21 | E3 ubiquitin-protein ligase TRIM21 (EC 2.3.2.27) (52 kDa Ro protein) (52 kDa ribonucleoprotein autoantigen Ro/SS-A) (RING finger protein 81) (Ro(SS-A)) (Sjoegren syndrome type A antigen) (SS-A) (Tripartite motif-containing protein 21) | 5 | UniProt   NCBI |
ISG15 | Ubiquitin-like protein ISG15 (Interferon-induced 15 kDa protein) (Interferon-induced 17 kDa protein) (IP17) (Ubiquitin cross-reactive protein) (hUCRP) | 5 | UniProt   NCBI |
IFNA21 | Interferon alpha-21 (IFN-alpha-21) (Interferon alpha-F) (LeIF F) | 5 | UniProt   NCBI |
IFNA2 | Interferon alpha-2 (IFN-alpha-2) (Interferon alpha-A) (LeIF A) | 5 | UniProt   NCBI |
IFNA16 | Interferon alpha-16 (IFN-alpha-16) (Interferon alpha-WA) | 4 | UniProt   NCBI |
UBA7 | Ubiquitin-like modifier-activating enzyme 7 (Ubiquitin-activating enzyme 7) (EC 6.2.1.-) (D8) (Ubiquitin-activating enzyme E1 homolog) | 5 | UniProt   NCBI |
IFNA4 | Interferon alpha-4 (IFN-alpha-4) (Interferon alpha-4B) (Interferon alpha-76) (Interferon alpha-M1) | 5 | UniProt   NCBI |
UBR3 | E3 ubiquitin-protein ligase UBR3 (EC 2.3.2.27) (N-recognin-3) (RING-type E3 ubiquitin transferase UBR3) (Ubiquitin-protein ligase E3-alpha-3) (Ubiquitin-protein ligase E3-alpha-III) (Zinc finger protein 650) | 5 | UniProt   NCBI |
Enrichments
Term ID | Corrected Pval | Fraction Complex Coverage | Proteins | Term Name |
---|---|---|---|---|
  REAC:R-HSA-168928 | 1.21460704755e-20 | 0.733333333333 | IFNA7 IFNA5 UBA7 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | DDX58/IFIH1-mediated induction of interferon-alpha/beta |
  REAC:R-HSA-912694 | 1.45671678938e-20 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Regulation of IFNA/IFNB signaling |
  GO:0005132 | 3.41443923459e-20 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | type I interferon receptor binding |
  WP:WP4912 | 9.44025875901e-20 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | SARS coronavirus and innate immunity |
  GO:0033141 | 1.45006339962e-19 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
  REAC:R-HSA-933541 | 1.78130695055e-19 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | TRAF6 mediated IRF7 activation |
  KEGG:04622 | 2.46647840554e-19 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | RIG-I-like receptor signaling pathway |
  GO:0033139 | 2.75410132413e-19 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | regulation of peptidyl-serine phosphorylation of STAT protein |
  WP:WP4558 | 4.65026078781e-19 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Overview of interferons mediated signaling pathway |
  WP:WP4655 | 4.80689235925e-19 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | Cytosolic DNA sensing pathway |
  GO:0042501 | 5.005604557e-19 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | serine phosphorylation of STAT protein |
  REAC:R-HSA-909733 | 6.53300491883e-19 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | Interferon alpha/beta signaling |
  REAC:R-HSA-913531 | 7.83613994998e-19 | 0.8 | IFNA7 IFNA5 UBA7 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA16 IFNA6 TRIM21 | Interferon Signaling |
  KEGG:05320 | 9.2234972741e-19 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Autoimmune thyroid disease |
  GO:0002323 | 3.89090703779e-18 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | natural killer cell activation involved in immune response |
  GO:0009615 | 1.71735099804e-16 | 0.866666666667 | IFNA7 IFNA5 IFNA2 IFNA17 IFNA21 IFNA4 IFI44 IFNA14 IFI44L ISG15 IFNA16 IFNA6 TRIM21 | response to virus |
  GO:0060337 | 1.8308883831e-16 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | type I interferon-mediated signaling pathway |
  GO:0043330 | 2.09261735452e-16 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | response to exogenous dsRNA |
  GO:0071357 | 2.16310156166e-16 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | cellular response to type I interferon |
  KEGG:04623 | 2.16941191371e-16 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Cytosolic DNA-sensing pathway |
  REAC:R-HSA-9705671 | 4.03515943034e-16 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | SARS-CoV-2 activates/modulates innate and adaptive immune responses |
  GO:0034340 | 4.78607284599e-16 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | response to type I interferon |
  GO:0043331 | 6.27130315598e-16 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | response to dsRNA |
  KEGG:04620 | 1.70024097808e-15 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Toll-like receptor signaling pathway |
  WP:WP75 | 2.12660606799e-15 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Toll like receptor signaling pathway |
  WP:WP5095 | 2.38091439118e-15 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Overview of proinflammatory and profibrotic mediators |
  GO:0140888 | 3.75754606475e-15 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | interferon-mediated signaling pathway |
  KEGG:05169 | 1.01383070494e-14 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | Epstein-Barr virus infection |
  KEGG:04650 | 1.40174944348e-14 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Natural killer cell mediated cytotoxicity |
  GO:0098586 | 1.87054719869e-14 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | cellular response to virus |
  GO:0042100 | 2.22791087599e-14 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | B cell proliferation |
  KEGG:05171 | 3.28080893758e-14 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | Coronavirus disease - COVID-19 |
  KEGG:04936 | 4.63928532214e-14 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Alcoholic liver disease |
  KEGG:05162 | 4.63928532214e-14 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Measles |
  KEGG:04630 | 7.70936236398e-14 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | JAK-STAT signaling pathway |
  KEGG:05160 | 7.70936236398e-14 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Hepatitis C |
  GO:0030101 | 8.07503215245e-14 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | natural killer cell activation |
  REAC:R-HSA-9705683 | 8.29458743158e-14 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | SARS-CoV-2-host interactions |
  WP:WP4630 | 8.38833929894e-14 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Measles virus infection |
  KEGG:04217 | 1.16560231796e-13 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Necroptosis |
  KEGG:05164 | 1.84491763999e-13 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Influenza A |
  GO:0033138 | 1.90257424833e-13 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | positive regulation of peptidyl-serine phosphorylation |
  KEGG:05152 | 2.09466518341e-13 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Tuberculosis |
  KEGG:04621 | 2.09466518341e-13 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | NOD-like receptor signaling pathway |
  GO:0046425 | 2.17794598737e-13 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | regulation of receptor signaling pathway via JAK-STAT |
  WP:WP4666 | 2.27162940633e-13 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Hepatitis B infection |
  KEGG:05161 | 2.37397416143e-13 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Hepatitis B |
  GO:1904892 | 3.66752312957e-13 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | regulation of receptor signaling pathway via STAT |
  GO:0002286 | 4.1586314672e-13 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | T cell activation involved in immune response |
  KEGG:05167 | 7.59822534358e-13 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Kaposi sarcoma-associated herpesvirus infection |
  GO:0030183 | 8.53521512544e-13 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | B cell differentiation |
  KEGG:05417 | 1.42839902157e-12 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Lipid and atherosclerosis |
  KEGG:05165 | 1.46023909908e-12 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | Human papillomavirus infection |
  GO:0033135 | 2.05087479329e-12 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | regulation of peptidyl-serine phosphorylation |
  REAC:R-HSA-983231 | 2.14453834571e-12 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Factors involved in megakaryocyte development and platelet production |
  KEGG:05163 | 2.57490354024e-12 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Human cytomegalovirus infection |
  KEGG:05170 | 2.69984057773e-12 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Human immunodeficiency virus 1 infection |
  GO:0043207 | 2.89327101896e-12 | 0.933333333333 | IFNA7 IFNA5 IFNA2 IFNA17 IFNA21 IFNA4 IFI44 IFNA14 IFI44L ISG15 IFNA16 IFNA6 UBA7 TRIM21 | response to external biotic stimulus |
  GO:0051707 | 2.89327101896e-12 | 0.933333333333 | IFNA7 IFNA5 IFNA2 IFNA17 IFNA21 IFNA4 IFI44 IFNA14 IFI44L ISG15 IFNA16 IFNA6 UBA7 TRIM21 | response to other organism |
  REAC:R-HSA-1280215 | 2.99621255413e-12 | 0.8 | IFNA7 IFNA5 UBA7 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA16 IFNA6 TRIM21 | Cytokine Signaling in Immune system |
  KEGG:04060 | 3.25509160408e-12 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Cytokine-cytokine receptor interaction |
  REAC:R-HSA-9694516 | 3.63509550995e-12 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | SARS-CoV-2 Infection |
  GO:0009607 | 4.57887472525e-12 | 0.933333333333 | IFNA7 IFNA5 IFNA2 IFNA17 IFNA21 IFNA4 IFI44 IFNA14 IFI44L ISG15 IFNA16 IFNA6 UBA7 TRIM21 | response to biotic stimulus |
  GO:0140546 | 1.34537612305e-11 | 0.866666666667 | IFNA7 IFNA5 UBA7 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 IFI44L ISG15 IFNA16 IFNA6 TRIM21 | defense response to symbiont |
  GO:0044419 | 1.82084232488e-11 | 0.933333333333 | IFNA7 IFNA5 IFNA2 IFNA17 IFNA21 IFNA4 IFI44 IFNA14 IFI44L ISG15 IFNA16 IFNA6 UBA7 TRIM21 | biological process involved in interspecies interaction between organisms |
  GO:0007259 | 1.86551082569e-11 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | receptor signaling pathway via JAK-STAT |
  GO:0097696 | 2.56942045323e-11 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | receptor signaling pathway via STAT |
  GO:0002285 | 3.00278656334e-11 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | lymphocyte activation involved in immune response |
  GO:0098542 | 3.62312335134e-11 | 0.866666666667 | IFNA7 IFNA5 UBA7 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 IFI44L ISG15 IFNA16 IFNA6 TRIM21 | defense response to other organism |
  GO:0006955 | 4.88101872623e-11 | 0.933333333333 | IFNA7 IFNA5 IFNA2 IFNA17 IFNA21 IFNA4 IFI44 IFNA14 IFI44L ISG15 IFNA16 IFNA6 UBA7 TRIM21 | immune response |
  GO:0005125 | 7.2531243841e-11 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | cytokine activity |
  REAC:R-HSA-9679506 | 9.04873364921e-11 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | SARS-CoV Infections |
  KEGG:04151 | 9.56062048438e-11 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | PI3K-Akt signaling pathway |
  WP:WP4172 | 1.1456737984e-10 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | PI3K Akt signaling pathway |
  GO:0045087 | 1.50533241679e-10 | 0.8 | IFNA7 IFNA5 UBA7 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA16 IFNA6 TRIM21 | innate immune response |
  GO:0042113 | 1.51743366429e-10 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | B cell activation |
  GO:0046651 | 2.66044582294e-10 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | lymphocyte proliferation |
  REAC:R-HSA-168249 | 2.710067809e-10 | 0.8 | IFNA7 IFNA5 UBA7 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA16 IFNA6 TRIM21 | Innate Immune System |
  GO:0032943 | 3.18367735424e-10 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | mononuclear cell proliferation |
  GO:0002366 | 4.2607297868e-10 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | leukocyte activation involved in immune response |
  GO:0002263 | 5.34343763686e-10 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | cell activation involved in immune response |
  GO:0005126 | 5.34343763686e-10 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | cytokine receptor binding |
  GO:0006959 | 6.30901697761e-10 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | humoral immune response |
  GO:0018105 | 7.03584696304e-10 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | peptidyl-serine phosphorylation |
  GO:0070661 | 7.83603372679e-10 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | leukocyte proliferation |
  KEGG:05168 | 8.99943279718e-10 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Herpes simplex virus 1 infection |
  GO:0018209 | 1.25270594192e-09 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | peptidyl-serine modification |
  GO:0034097 | 2.97764977292e-09 | 0.733333333333 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA16 IFNA6 TRIM21 | response to cytokine |
  GO:0002250 | 3.75207131075e-09 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | adaptive immune response |
  GO:0006952 | 3.793096484e-09 | 0.866666666667 | IFNA7 IFNA5 UBA7 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 IFI44L ISG15 IFNA16 IFNA6 TRIM21 | defense response |
  GO:0019221 | 4.08823621741e-09 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | cytokine-mediated signaling pathway |
  KEGG:05200 | 5.13925390983e-09 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Pathways in cancer |
  GO:0009605 | 8.42454671074e-09 | 0.933333333333 | IFNA7 IFNA5 IFNA2 IFNA17 IFNA21 IFNA4 IFI44 IFNA14 IFI44L ISG15 IFNA16 IFNA6 UBA7 TRIM21 | response to external stimulus |
  GO:0002376 | 1.02416032323e-08 | 0.933333333333 | IFNA7 IFNA5 IFNA2 IFNA17 IFNA21 IFNA4 IFI44 IFNA14 IFI44L ISG15 IFNA16 IFNA6 UBA7 TRIM21 | immune system process |
  GO:0030098 | 1.41900319849e-08 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | lymphocyte differentiation |
  GO:1903131 | 4.0697118615e-08 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | mononuclear cell differentiation |
  REAC:R-HSA-9824446 | 4.498820069e-08 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | Viral Infection Pathways |
  GO:0048018 | 4.82179109222e-08 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | receptor ligand activity |
  GO:0030546 | 5.50958870517e-08 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | signaling receptor activator activity |
  GO:0071345 | 6.0444293537e-08 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | cellular response to cytokine stimulus |
  GO:0030545 | 1.0752970089e-07 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | signaling receptor regulator activity |
  REAC:R-HSA-109582 | 1.15051270773e-07 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Hemostasis |
  GO:0042110 | 1.89010804714e-07 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | T cell activation |
  REAC:R-HSA-5663205 | 3.39688991714e-07 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | Infectious disease |
  GO:0002521 | 4.30300182292e-07 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | leukocyte differentiation |
  REAC:R-HSA-168256 | 5.26357099403e-07 | 0.8 | IFNA7 IFNA5 UBA7 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA16 IFNA6 TRIM21 | Immune System |
  GO:0014070 | 5.29217380901e-07 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | response to organic cyclic compound |
  GO:0002252 | 6.47765201552e-07 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | immune effector process |
  TF:M03575 | 8.08730976675e-07 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Factor: HEN2; motif: CATYTGNNN |
  TF:M08395 | 9.16288990838e-07 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFI44 IFNA14 IFI44L IFNA4 IFNA16 TRIM21 | Factor: PBX4:HOXA10; motif: NCATAAATCA |
  GO:0031399 | 1.56981781498e-06 | 0.733333333333 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA16 IFNA6 TRIM21 | regulation of protein modification process |
  GO:0001934 | 1.63097300239e-06 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | positive regulation of protein phosphorylation |
  GO:0042327 | 2.58207587138e-06 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | positive regulation of phosphorylation |
  GO:0046649 | 4.15933702048e-06 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | lymphocyte activation |
  GO:0010562 | 7.89791032585e-06 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | positive regulation of phosphorus metabolic process |
  GO:0045937 | 7.89791032585e-06 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | positive regulation of phosphate metabolic process |
  TF:M09952 | 1.07968896339e-05 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFI44 TRIM21 IFNA4 IFNA16 IFNA14 | Factor: hoxa9; motif: NTGATTTATKR |
  GO:0030097 | 1.40979350168e-05 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | hemopoiesis |
  TF:M00672_1 | 1.71730443066e-05 | 0.733333333333 | IFNA7 IFNA5 IFNA2 IFNA17 IFNA21 IFI44 IFNA14 IFNA4 IFNA6 UBA7 IFNA16 | Factor: TEF; motif: ATGTTWAYATAA; match class: 1 |
  GO:1901698 | 2.05513548517e-05 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | response to nitrogen compound |
  GO:0045321 | 2.4664333394e-05 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | leukocyte activation |
  GO:0031401 | 2.67629354059e-05 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | positive regulation of protein modification process |
  GO:0018193 | 3.29755761754e-05 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | peptidyl-amino acid modification |
  GO:0036211 | 3.4372457745e-05 | 0.866666666667 | IFNA7 IFNA5 UBA7 IFNA17 IFNA21 UBR3 IFNA4 IFNA2 IFNA14 ISG15 IFNA16 IFNA6 TRIM21 | protein modification process |
  TF:M07278_1 | 3.62777645412e-05 | 0.533333333333 | IFNA7 IFNA17 IFNA21 IFI44 IFNA14 IFNA4 IFNA6 IFNA16 | Factor: Dlx-3; motif: NTAATTNVN; match class: 1 |
  REAC:R-HSA-1643685 | 6.34543773646e-05 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | Disease |
  GO:0001932 | 7.78951039235e-05 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | regulation of protein phosphorylation |
  GO:0043412 | 9.78375956191e-05 | 0.866666666667 | IFNA7 IFNA5 UBA7 IFNA17 IFNA21 UBR3 IFNA4 IFNA2 IFNA14 ISG15 IFNA16 IFNA6 TRIM21 | macromolecule modification |
  GO:0001775 | 0.00010046131799 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | cell activation |
  GO:0042325 | 0.000143212482005 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | regulation of phosphorylation |
  TF:M12625_1 | 0.000170070003809 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Factor: HOXD1; motif: NATYCAKCAN; match class: 1 |
  TF:M08500 | 0.00017234684362 | 0.266666666667 | IFNA17 IFNA4 IFNA2 IFNA7 | Factor: HOXB2:ETV7; motif: TAATGRNSMGGAARYRCTTCCGS |
  GO:0005102 | 0.000175272096354 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | signaling receptor binding |
  TF:M01420_1 | 0.000177251791785 | 0.733333333333 | IFNA7 IFNA5 IFNA2 IFNA17 IFNA21 IFI44 IFNA14 IFI44L IFNA4 IFNA6 TRIM21 | Factor: Ncx; motif: NAATNAATTAATAANWW; match class: 1 |
  TF:M11571_1 | 0.000226665562498 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | Factor: HNF-3alpha; motif: YTRWGTMAATATTTRCWYWN; match class: 1 |
  GO:0140677 | 0.000231517760347 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | molecular function activator activity |
  GO:0010033 | 0.00026409496971 | 0.733333333333 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA16 IFNA6 TRIM21 | response to organic substance |
  GO:0006950 | 0.000353466275576 | 0.866666666667 | IFNA7 IFNA5 UBA7 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 IFI44L ISG15 IFNA16 IFNA6 TRIM21 | response to stress |
  TF:M04238 | 0.000364739813056 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | Factor: FOXD2; motif: NRNWAATATTTAYN |
  TF:M07362 | 0.000558168764304 | 0.666666666667 | IFNA7 IFNA5 UBA7 IFNA17 IFNA21 IFI44 IFNA14 IFI44L IFNA4 IFNA16 | Factor: nanog; motif: CCATTAAAWNGTK |
  GO:0071310 | 0.000563130424049 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | cellular response to organic substance |
  GO:0019220 | 0.000600861892226 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | regulation of phosphate metabolic process |
  GO:0051174 | 0.000607667975081 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | regulation of phosphorus metabolic process |
  GO:0051246 | 0.000688386511926 | 0.733333333333 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA16 IFNA6 TRIM21 | regulation of protein metabolic process |
  TF:M10031_1 | 0.000770828686893 | 0.8 | IFNA7 IFNA5 IFNA2 IFNA17 IFNA21 IFI44 IFNA14 IFI44L IFNA4 IFNA16 IFNA6 TRIM21 | Factor: ipf1; motif: TGATTGATK; match class: 1 |
  TF:M01127 | 0.000782978468886 | 0.4 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA16 | Factor: islet1; motif: GSNTAATRK |
  GO:0070887 | 0.000912814499373 | 0.733333333333 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA16 IFNA6 TRIM21 | cellular response to chemical stimulus |
  GO:0044877 | 0.000967432155011 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | protein-containing complex binding |
  TF:M04383_1 | 0.00103761275973 | 0.733333333333 | IFNA7 IFNA5 UBA7 IFNA17 IFNA21 UBR3 IFNA14 IFNA4 IFNA16 IFNA6 TRIM21 | Factor: LBX2; motif: CTNRANSTAATTA; match class: 1 |
  TF:M00795_1 | 0.00127033824077 | 0.533333333333 | IFNA7 IFNA5 IFNA2 IFNA17 IFNA21 IFI44 IFNA16 IFNA4 | Factor: Octamer; motif: TNATTTGCATN; match class: 1 |
  GO:0006468 | 0.00178207906582 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | protein phosphorylation |
  TF:M00423_1 | 0.00198529599395 | 0.733333333333 | IFNA7 IFNA5 IFNA2 IFNA17 IFNA21 IFI44 IFNA14 IFI44L IFNA4 IFNA16 TRIM21 | Factor: FOXJ2; motif: AYMATAATATTTKN; match class: 1 |
  TF:M11927 | 0.00214994395954 | 0.666666666667 | IFNA7 IFNA5 UBA7 IFNA17 IFNA21 IFNA2 IFNA14 IFI44L IFNA4 IFNA16 | Factor: POU3F1; motif: TAATKANNNNNTMATTA |
  TF:M04063_1 | 0.00226900623956 | 0.533333333333 | IFNA7 IFNA5 IFNA17 IFNA21 IFI44 IFNA16 IFNA6 IFNA4 | Factor: Pax-4; motif: SWAATWAN; match class: 1 |
  TF:M00131 | 0.00229161814568 | 0.733333333333 | IFNA7 IFNA5 UBA7 IFNA17 IFNA21 IFNA2 IFNA14 IFI44L IFNA4 IFNA6 IFNA16 | Factor: HNF3beta; motif: KGNANTRTTTRYTTW |
  TF:M04082_1 | 0.00234047831732 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFI44 IFNA14 IFNA4 IFNA6 IFNA16 | Factor: POU3F3; motif: WTNAATAWKNAW; match class: 1 |
  GO:0051247 | 0.00247840978866 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | positive regulation of protein metabolic process |
  TF:M00802_1 | 0.00291192838706 | 0.533333333333 | IFNA7 IFNA2 IFNA17 IFNA21 IFI44 IFNA14 IFNA4 IFNA16 | Factor: Pit-1; motif: NMTTCATAAWTATWNMNA; match class: 1 |
  TF:M07453 | 0.00355923255745 | 0.466666666667 | IFNA7 IFNA17 IFNA21 TRIM21 IFNA16 IFNA4 IFNA14 | Factor: Meis1b:Hoxa9:Pbx1a; motif: RTGATTTATGNS |
  WP:WP4341 | 0.0037193117608 | 0.2 | IFI44L IFNA2 ISG15 | Non genomic actions of 1 25 dihydroxyvitamin D3 |
  GO:0016310 | 0.00379595655082 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | phosphorylation |
  TF:M07120_1 | 0.00412190235651 | 0.533333333333 | IFNA7 IFNA5 IFNA2 IFNA17 IFNA21 IFI44 IFNA16 IFNA4 | Factor: Oct-2; motif: NNNATTTGCATRT; match class: 1 |
  TF:M00672 | 0.00519875308223 | 0.933333333333 | IFNA7 IFNA5 IFNA2 IFNA17 IFNA21 UBR3 IFI44 IFNA14 IFI44L IFNA4 IFNA16 IFNA6 UBA7 TRIM21 | Factor: TEF; motif: ATGTTWAYATAA |
  TF:M11927_1 | 0.00621026171743 | 0.533333333333 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA16 IFI44L IFNA4 | Factor: POU3F1; motif: TAATKANNNNNTMATTA; match class: 1 |
  TF:M11582_1 | 0.00624235062122 | 0.266666666667 | IFNA4 IFNA17 IFNA6 IFNA21 | Factor: FOXI1; motif: AAYRTAAACAAT; match class: 1 |
  TF:M04695 | 0.00797771632776 | 0.533333333333 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA16 IFNA6 IFNA4 | Factor: REST; motif: TTCAGCACCAYGGA |
  TF:M00291_1 | 0.00859530809839 | 0.533333333333 | IFNA5 IFNA17 IFNA21 IFI44 IFNA14 IFNA4 IFNA6 IFNA16 | Factor: Freac-3; motif: NNNNNGTAAATAAACA; match class: 1 |
  TF:M11909_1 | 0.00877917575672 | 0.533333333333 | IFNA7 IFNA2 IFNA17 IFNA21 IFI44 IFNA16 UBR3 IFNA4 | Factor: POU3F2; motif: NTATGCWAATKAG; match class: 1 |
  TF:M00161 | 0.00921021797116 | 0.733333333333 | IFNA7 IFNA5 IFNA2 IFNA17 IFNA21 IFI44 TRIM21 IFNA4 IFNA16 UBR3 IFNA14 | Factor: Oct-1; motif: MKVATTTGCATATT |
  TF:M07254 | 0.0111206767385 | 1.0 | IFNA7 IFNA5 IFNA2 IFNA17 IFNA21 UBR3 IFNA4 IFI44 IFNA14 IFI44L ISG15 IFNA16 IFNA6 UBA7 TRIM21 | Factor: Foxc1; motif: TTVYTTTNW |
  GO:0008283 | 0.011556581064 | 0.6 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA2 IFNA14 IFNA4 IFNA6 IFNA16 | cell population proliferation |
  GO:0042221 | 0.0120126614662 | 0.733333333333 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA16 IFNA6 TRIM21 | response to chemical |
  TF:M12618 | 0.0138896216266 | 0.466666666667 | IFNA5 IFI44L IFNA21 IFNA2 IFNA14 IFNA6 TRIM21 | Factor: HNF1B; motif: GTTAAWCATTAACYNN |
  TF:M10651 | 0.014930176343 | 0.6 | IFNA7 IFNA5 UBA7 IFNA17 IFNA21 IFNA4 IFNA14 ISG15 IFNA16 | Factor: HOX11L2; motif: YAATTGNNNNNNNNNCAATTN |
  TF:M01010_1 | 0.0153219240279 | 0.733333333333 | IFNA7 IFNA5 IFNA17 IFNA21 IFI44 IFNA14 IFI44L IFNA4 IFNA16 IFNA6 TRIM21 | Factor: HMGIY; motif: NNKKNAWTTTNYTNN; match class: 1 |
  GO:0009966 | 0.0163713621065 | 0.733333333333 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA16 IFNA6 TRIM21 | regulation of signal transduction |
  TF:M11896_1 | 0.0164440274096 | 0.533333333333 | IFNA7 IFNA5 IFNA2 IFNA17 IFNA21 IFI44 IFNA16 IFNA4 | Factor: Oct-2; motif: NTATGCWAATN; match class: 1 |
  GO:0019538 | 0.0218782236514 | 0.866666666667 | IFNA7 IFNA5 UBA7 IFNA17 IFNA21 UBR3 IFNA4 IFNA2 IFNA14 ISG15 IFNA16 IFNA6 TRIM21 | protein metabolic process |
  TF:M04897 | 0.03067331448 | 0.666666666667 | IFNA7 IFNA17 IFNA21 UBR3 IFNA2 IFNA14 IFNA4 IFNA16 IFNA6 TRIM21 | Factor: Fra-1; motif: ACTCATG |
  TF:M07058 | 0.0307187021671 | 0.733333333333 | IFNA7 IFNA5 IFNA2 IFNA17 IFNA21 IFI44 TRIM21 IFI44L IFNA4 UBR3 IFNA16 | Factor: POU2F1; motif: ATTTGCATN |
  TF:M00195_1 | 0.0334775437102 | 0.4 | IFNA7 IFNA17 IFNA21 IFI44 IFNA16 IFNA4 | Factor: Oct-1; motif: NNNNATGCAAATNAN; match class: 1 |
  TF:M01400_1 | 0.0360233685217 | 0.466666666667 | IFNA7 IFNA5 UBA7 IFNA17 IFNA21 IFNA14 IFNA16 | Factor: Dlx-3; motif: NNNNNATAATTACMNNN; match class: 1 |
  WP:WP619 | 0.0377812718473 | 0.133333333333 | ISG15 IFNA2 | Type II interferon signaling |
  GO:0007166 | 0.0414918223086 | 0.666666666667 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA6 IFNA16 | cell surface receptor signaling pathway |
  GO:0023051 | 0.043022508513 | 0.733333333333 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA16 IFNA6 TRIM21 | regulation of signaling |
  GO:0031325 | 0.0432207266217 | 0.733333333333 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA16 IFNA6 TRIM21 | positive regulation of cellular metabolic process |
  GO:0010646 | 0.0436196201139 | 0.733333333333 | IFNA7 IFNA5 IFNA17 IFNA21 IFNA4 IFNA2 IFNA14 ISG15 IFNA16 IFNA6 TRIM21 | regulation of cell communication |
  TF:M11935 | 0.0476804187052 | 0.8 | IFNA7 IFNA5 UBA7 IFI44L IFNA21 UBR3 IFNA4 IFNA2 TRIM21 ISG15 IFNA6 IFNA16 | Factor: Oct3; motif: NNWTATGYWAATKANN |
Edges
Protein 1 | Protein 2 | Score | ProteomeHD | Interface Overlap |
---|---|---|---|---|
 IFNA5 |  IFNA16 | 0.999 |            |
mixed_interface        
|
 IFNA5 |  IFNA14 | 0.998 |            |
mutually_exclusive (P05161)        
structurally_consistent (dimer)         |
 IFNA21 |  ISG15 | 0.997 |            |
structurally_consistent (P01570)        
|
 IFNA14 |  IFNA1 | 0.996 |            |          |
 IFI44 |  IFNA21 | 0.996 |            |
structurally_consistent (Q53G44)        
structurally_consistent (dimer)         |
 IFNA7 |  IFNA4 | 0.995 |            |
structurally_consistent (dimer)        
|
 IFNA21 |  IFNA4 | 0.995 |            |
mixed_interface        
|
 ISG15 |  IFNA14 | 0.995 |            |
mutually_exclusive (P01569)        
structurally_consistent (dimer)         |
 IFNA21 |  IFNA6 | 0.994 |            |
structurally_consistent (dimer)        
|
 ISG15 |  IFNA1 | 0.994 |            |          |
 IFNA21 |  UBR3 | 0.994 |            |          |
 IFNA6 |  IFNA1 | 0.993 |            |          |
 IFNA5 |  IFNA2 | 0.993 |            |
structurally_consistent (dimer)        
|
 ISG15 |  UBA7 | 0.993 | 0.134           |
structurally_consistent (dimer)        
|
 IFI44L |  IFNA21 | 0.993 |            |
structurally_consistent (dimer)        
|
 IFNA2 |  IFNA4 | 0.992 |            |
structurally_consistent (P01569)        
structurally_consistent (dimer)         |
 ISG15 |  IFNA4 | 0.992 |            |          |
 IFNA5 |  IFNA6 | 0.992 |            |
structurally_consistent (dimer)        
|
 IFNA21 |  IFNA14 | 0.991 |            |
structurally_consistent (dimer)        
|
 IFNA21 |  IFNA1 | 0.99 |            |
mixed_interface        
|
 IFNA5 |  IFNA17 | 0.989 |            |
mixed_interface        
|
 IFNA5 |  IFNA4 | 0.989 |            |
structurally_consistent (dimer)        
|
 IFNA2 |  ISG15 | 0.989 |            |
mutually_exclusive (P01569)        
|
 IFI44L |  IFNA5 | 0.989 |            |          |
 IFNA7 |  IFNA16 | 0.989 |            |          |
 TRIM21 |  IFNA14 | 0.988 |            |          |
 IFNA7 |  ISG15 | 0.987 |            |
structurally_consistent (dimer)        
|
 IFNA6 |  ISG15 | 0.986 |            |
mutually_exclusive (P01569)        
|
 IFNA5 |  UBR3 | 0.986 |            |          |
 ISG15 |  IFNA16 | 0.982 |            |          |
 IFNA1 |  IFNA4 | 0.981 |            |
structurally_consistent (dimer)        
|
 IFNA5 |  ISG15 | 0.979 |            |
structurally_consistent (dimer)        
|
 IFNA7 |  UBR3 | 0.978 |            |          |
 IFNA5 |  TRIM21 | 0.976 |            |          |
 IFNA6 |  IFNA4 | 0.97 |            |          |
 IFNA6 |  IFNA14 | 0.969 |            |
mutually_exclusive (P01568)        
|
 ISG15 |  UBR3 | 0.966 | 0.098           |          |
 IFNA17 |  IFNA1 | 0.963 |            |
mixed_interface        
|
 IFNA21 |  TRIM21 | 0.958 |            |          |
 IFNA14 |  IFNA4 | 0.953 |            |          |
 TRIM21 |  IFNA16 | 0.941 |            |          |
 IFNA16 |  UBR3 | 0.925 |            |          |
 IFNA5 |  IFNA1 | 0.917 |            |
structurally_consistent (dimer)        
|
 TRIM21 |  IFNA4 | 0.903 |            |          |
 IFNA6 |  TRIM21 | 0.879 |            |          |
 IFNA14 |  IFNA16 | 0.868 |            |          |
 IFNA2 |  TRIM21 | 0.868 |            |          |
 ISG15 |  TRIM21 | 0.766 | 0.08           |          |
 TRIM21 |  IFNA1 | 0.683 |            |          |
 IFNA1 |  IFNA16 | 0.675 |            |
mixed_interface        
|
 IFNA6 |  UBR3 | 0.612 |            |          |
 IFI44 |  IFI44L | 0.572 | 0.378           |
structurally_consistent (dimer)        
|
 IFI44 |  IFNA14 | 0.572 |            |
structurally_consistent (P01568)        
|
 IFI44 |  IFNA1 | 0.543 |            |          |
 IFNA7 |  TRIM21 | 0.536 |            |          |
 IFI44 |  IFNA6 | 0.502 |            |
structurally_consistent (P01568)        
|
 IFI44L |  IFNA16 | 0.502 |            |          |
 IFNA2 |  IFNA7 | 0.502 |            |
mutually_exclusive (P05014)        
|
 IFI44 |  IFNA4 | 0.502 |            |          |
 IFI44L |  IFNA14 | 0.49 |            |
structurally_consistent (P01568)        
|
 IFI44L |  IFNA6 | 0.49 |            |
structurally_consistent (P01568)        
|
 IFI44L |  IFNA4 | 0.391 |            |          |
 IFI44L |  IFNA1 | 0.391 |            |          |
 TRIM21 |  UBR3 | 0.343 | 0.07           |          |
 IFI44L |  IFNA17 | 0.341 |            |          |
 IFNA4 |  IFNA16 | 0.333 |            |          |
 IFNA21 |  IFNA2 | 0.333 |            |
structurally_consistent (P05014)        
|
 IFNA21 |  IFNA7 | 0.333 |            |
structurally_consistent (P05014)        
|
 IFNA2 |  IFNA1 | 0.333 |            |          |
 IFNA6 |  IFNA16 | 0.333 |            |
mutually_exclusive (P01569)        
|
 IFNA7 |  IFNA1 | 0.318 |            |          |
 IFNA17 |  IFNA4 | 0.3 |            |          |
 IFNA6 |  IFNA17 | 0.281 |            |
mutually_exclusive (P01569)        
|
 IFI44L |  ISG15 | 0.281 | 0.052           |          |
 IFNA14 |  IFNA17 | 0.281 |            |          |
 ISG15 |  IFNA17 | 0.27 |            |
mutually_exclusive (P01569)        
|
 IFI44L |  TRIM21 | 0.245 | 0.08           |          |
 IFNA1 |  UBR3 | 0.239 |            |          |
 IFNA2 |  UBR3 | 0.226 |            |          |
 IFI44L |  UBR3 | 0.205 | 0.07           |          |
 IFI44 |  TRIM21 | 0.184 | 0.028           |          |
 IFNA14 |  UBR3 | 0.173 |            |          |
 IFI44 |  UBR3 | 0.165 | 0.03           |          |
 IFNA17 |  IFNA16 | 0.15 |            |          |
 IFI44 |  ISG15 | 0.143 | 0.164235294118           |          |
 IFNA21 |  IFNA17 | 0.143 |            |
mutually_exclusive (P01562)        
|
 TRIM21 |  IFNA17 | 0.133 |            |          |
 IFNA4 |  UBR3 | 0.13 |            |          |
 IFNA17 |  UBR3 | 0.056 |            |          |
 UBA7 |  TRIM21 | 0.002 | 0.16           |          |
Related Complexes